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ABSTRACT 
 
PldB, a Putative Phospholipase D Homologue, Mediates Quorum Sensing in 
Dictyostelium discoideum Development 
 
by 
 
Yi Chen 
 
 
Adviser: Derrick Brazill, Ph.D. 
 
 
Quorum sensing, the ability to measure the local cell density, is required for animal cells 
to achieve proper cell growth, differentiation and development. However, because of the 
genetic intractability of mammalian cells, we study quorum sensing in the genetically 
pliable unicellular eukaryote Dictyostelium discoideum. D. discoideum cells live as 
individual cells under vegetative conditions. Starvation sets off development to a 
multicellular organism. But cells won’t develop unless enough cells are under starvation 
conditions. Approximately 105 cells are needed to form a fruiting body, the final stage of 
the development. When starved, cells are able to calculate the concentration of 
surrounding starving cells by simultaneously secreting and sensing a glycoprotein named 
conditioned medium factor (CMF). A high density of starving cells results in a high level 
of CMF, which allows cell aggregation and development. Here, we describe the role of a 
putative phospholipase D (PLD) homologue, PldB, in quorum sensing pathways. PldB is 
present during early development when quorum sensing is occurring as well as in later 
development. pldB¯ cells can aggregate at low cell density. This phenotype is cell 
autonomous. Cells overexpressing pldB are unable to aggregate or form fruiting bodies 
even at high cell density. These observations imply that PldB is involved in quorum 
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sensing. CMF decreases cAMP-stimulated GTPase activity in wild-type cells, but not in 
pldB¯ cells, confirming that PldB mediates quorum sensing in the CMF signal pathway. 
pldB¯ cells develop faster than wild-type cells, indicating that pldB is involved in the 
timing of development. Analysis of early developmental gene expression shows that 
cAMP receptor cAR1, required in aggregation, is expressed at higher levels earlier in 
pldB¯ cells than in wild-type cells, which may explain the rapid development phenotype 
of pldB¯ cells. However, pldB¯ cells have normal chemotactic rate while pldBOE cells do 
not chemotax. Cell fractionation and Western blot analysis reveal that PldB protein is 
localized to cytoplasmic membrane as well as vesicles. PldB takes effect in quorum 
sensing through its phosphatidylcholine hydrolysis product, phosphatidic acid, since 
exogenous phosphatidic acid inhibits cell aggregation at low cell density, mimicking the 
phenotype of overexpressing pldB. Rapamycin promotes cell aggregation at lower cell 
densities for wild-type, pldB¯ and pldBOE cells, implying that TOR may have a role in 
quorum sensing downstream of PldB. The knowledge of PLD in quorum sensing will 
help us further understand this phenomenon in mammals, which may lead to therapeutic 
strategies for tissue/organ repair and cancer treatment.  
 v
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CHAPTER 1 
Introduction 
 
1.1 Quorum sensing 
Quorum sensing, the ability to measure the local cell density, is required for animal cells 
to achieve proper cell growth, differentiation and development. Typically, cells secrete 
signaling molecules that turn on one or more signaling cascades, which steer the 
developmental path of the cells. Quorum sensing mechanisms are present in mammals [1], 
Dictyostelium discoideum [2] and bacteria [3].  
 
Bacteria use quorum sensing to co-ordinate their behavior and respond quickly to 
changes in environmental conditions in order to survive. These responses include 
adaptation to availability of nutrients, defense against other microorganisms, which may 
compete for the same nutrients, and the avoidance of toxic compounds potentially 
dangerous for the bacteria. Vibrio fischeri, the first bacterium studied for quorum sensing, 
can secrete and sense a homoserine lactone molecule and therefore monitor the cell 
density [4]. They don’t emit light in the free-living planktonic state. But when they 
colonize the light organs of certain luminescent fish or squid and accumulate to a large 
number, the high concentration of the homoserine lactone molecule will turn on the 
luminescence genes of the bacterium, causing light production. 
 
As to mammalian cells, mice express and secrete an obese protein [1]. The level of 
expression of this obese gene signals the size of the adipose depot. A high level signal 
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may act on the central nervous system to inhibit food intake and/or regulate energy 
expenditure as part of a homeostatic mechanism to maintain constancy of the adipose 
tissue. 
 
Cell-cell communication and group organization are important for bacteria to evade host 
defenses and antibiotics in persistent bacterial infections. With the knowledge of quorum 
sensing in bacteria, we will be able to develop new therapeutic agents to control the 
virulence and treat these infectious diseases through regulating bacterial group behavior, 
instead of just killing or stopping the growth of individual bacteria. In mammals, 
knowledge of quorum sensing will pave the way for therapeutic strategies for tissue or 
organ repair/regeneration to benefit patients with lost limbs, nerve injuries, or damaged 
organs. Although promising for quorum sensing research, mammalian cells are 
genetically intractable. Hence we study eukaryotic quorum sensing in Dictyostelium 
discoideum, which is easily accessible to techniques of molecular cell biology, genetics 
and biochemistry.  
 
1.2 A model organism 
1935 saw the entry of Dictyostelium discoideum for biological research [5]. For the past 
70 years, it has been extensively studied worldwide for intracellular and intercellular 
signal transduction, cell motility, differentiation and morphogenesis. A unicellular 
eukaryote, D. discoideum provides a system to study cellular and developmental biology 
at a level of complexity greater than yeasts, but simpler than plants and animals. A 
proteome-based eukaryotic phylogeny shows that D. discoideum diverged from the 
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animal-fungal lineage after the plant-animal split [6]. Despite its early divergence, 
proteins of D. discoideum are more similar to human orthologues than are those of yeasts 
[7]. With its better approximation to the function and regulation of mammalian cells, its 
genetic pliability, and its multicellularity during development, D. discoideum makes it 
possible to study human disease orthologue proteins in an organism that shares both great 
similarity with higher eukaryotes and experimental tractability with yeasts. Moreover, D. 
discoideum cells are easy to grow with liquid nutrients. Cell number duplicates in 8-10 
hours. Cell development is initiated by simply removing the nutrients and normally 
completes within 24 hours. Mutations can affect development without affecting growth. 
Mutant strains can be easily selected by inserting a specific drug-resistant cassette into 
the genome. With the ease of mutating any gene of interest, its corresponding function or 
contribution to a certain biological process can be readily assessed by observing the 
changes in phenotype. These characteristics make D. discoideum a good model organism 
to work with. 
 
1.3 Life cycle 
A social amoeba (cellular slime mold), D. discoideum lives in soil, feeds on bacteria and 
reproduces by binary fission. Lack of bacteria or other nutrient sources forces vegetative 
individual cells to stop division and develop. This involves cell aggregation, 
differentiation and morphogenesis. Through multiple stages of development, 
approximately 105 cells will aggregate to form a fruiting body in 24 hours (Figure 1). A 
fruiting body consists of a mass of spore cells on the top of a column of stalk cells. The 
20% stalk cells are dead while the 80% spore cells are dormant living cells [8, 9]. Upon 
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availability of nutrient sources, the spore cells will germinate and develop back into 
individual cells, thus reinitiating the life cycle. In other words, starvation initiates the 
transformation from individual cells to a multicellular organism and nutrients reverse the 
process. The relatively short and simple life cycle of D. discoideum makes it ideal for 
study in development and differentiation. Moreover, an international consortium has 
completed the sequencing of D. discoideum genome [6]. D. discoideum has a 34 Mb 
haploid genome, which consists of 6 chromosomes encoding approximately 12,500 genes. 
It is now easy to identify a gene with its homologue in mammalian species and study its 
physiological functions. 
 
 
Figure 1. Post-aggregation stages of D. discoideum development. 
Moving clockwise from lower right, the stages are the loose aggregate, the tight aggregate (mound), the 
tipped aggregate, the finger, a slug, and then culmination stages from the Mexican hat stage to the final 
fruiting body. This scanning electron micrograph is by R. Lawrence Blanton & Mark Grimson at Texas 
Tech. University. 
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1.4 cAMP-cAR1-Gα2 signaling 
Starving D. discoideum cells have the ability to sense the density of other starving cells. 
Without this mechanism, small groups of cells that happen to starve at the same time 
would form small, ineffectual fruiting bodies.  Normally when the number of starving 
cells reaches a certain threshold (~105 cells), they will initiate aggregation by 
chemotaxing to extracellular cyclic AMP (cAMP) pulses, which occur every 6 minutes 
[10]. Cells have cAMP receptor, cAR1, on the cell surface [11]. This seven trans-
membrane domain glycoprotein is coupled with a heterotrimeric G protein (Gα2βγ) on 
the cytosol side of the plasma membrane [12]. Upon binding of cAMP to cAR1, GTP 
binds to Gα2, replacing GDP, and Gα2-GTP separates from βγ subunits [13]. Gα2-GTP 
will then activate the downstream guanylyl cyclase, which is needed for activation of 
genes required for motility [14] (Figure 2). Gβγ, together with cytosol regulator of 
adenylyl cyclase (CRAC) that is recruited to the cell membrane, will activate adenylyl 
cyclase (ACA) [15]. cAR1 is evenly distributed along the cell membrane [16]. Yet 
CRAC responds to the differential concentrations of cAMP across a cell and binds 
rapidly to the membrane side that encounters the highest concentrations of cAMP, 
translating the polarity of a cAMP wave into a polar response [15, 17-19]. ACA is a 12 
trans-membrane domain protein with 2 large intracellular loops [20]. It increases 
intracellular cAMP that is believed to regulate the gene expression needed for 
development and releases cAMP into the extracellular space to relay this aggregation 
signal to other starving cells [21].  
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Figure 2. cAMP signal pathway. 
cAMP binds to cell surface receptor cAR1, which is coupled with Gα2βγ protein. GTP replaces GDP on 
Gα2 and causes separation of Gα2-GTP from Gβγ. Upon separation, Gα2-GTP and Gβγ activate guanylyl 
cyclase and adenylyl cyclase respectively.  
 
 
1.5 CMF-Gα1 signaling  
It has been found that an 80-kDa secreted glycoprotein, conditioned medium factor 
(CMF), plays an indispensable role in the activation of cAMP signaling cascade [22-25]. 
CMF is heat stable and loses <10% of its activity after incubation at 80°C for 25 minutes 
[23]. Its glycosylation may help confer the stability. Neither pH (7.0 or below) of the 
environment nor light affects the accumulation or the activity threshold of CMF [26]. 
CMF has a diffusion trait, such that the level of CMF in the vicinity of an isolated 
starving cell will be too low to induce the expression of CMF-requiring genes, while the 
level in the vicinity of a high density of starving cells will induce the expression of CMF-
requiring genes [26]. All these characteristics make CMF a good quorum sensing factor. 
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Cells synthesize CMF under vegetative conditions. But only under starvation conditions 
do cells secrete and sense CMF [27]. When only a few cells are starving, the CMF level 
is low and cells do not respond to cAMP [23]. Once a large number of starving cells 
releases a high level of CMF (above 0.3 ng/ml), cells start to chemotax and aggregate 
[23]. Therefore, CMF helps coordinate the development of fruiting bodies with 
appropriate size by allowing aggregation only when most cells in a given area are 
starving, as characterized by a high level of CMF.  
 
CMF exerts control over development by regulating cAMP signaling through cAR1 [24]. 
With high cell density, and thus a high level of CMF, the cAMP-cAR1-Gα2 signaling 
cascade is activated. In the absence of CMF, cAMP can still bind to cAR1, and the 
activation of cAR1 can still cause Gα2 to release GDP and bind GTP. However, 
activation of downstream adenylyl and guanylyl cyclases is greatly inhibited [28]. This 
inhibition of adenylyl and guanylyl cyclases can be removed by a 10-second exposure of 
CMF, showing that lack of CMF is the direct cause of inhibition [28]. The presence or 
absence of CMF has no effect on the levels of cAMP-cAR1 induced binding of GTP to 
membranes [25], arguing that the lack of CMF has no effect on the interaction between 
cAR1 and its G protein in vitro. Thus, CMF controls aggregation by regulating cAMP 
signaling at a point after G protein activation but before the activations of adenylyl and 
guanylyl cyclases.  
 
CMF accomplishes this by controlling the GTPase rate of Gα2 [25]. It has been found 
that in cell lysates, approximately 250 molecules of GTP bind to a cell’s membrane in 
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response to a pulse of cAMP, regardless of whether CMF is present or absent. After 
cAMP stimulation, GTP is hydrolyzed to GDP at a rate of approximately 240 molecules 
in 3 minutes in the absence of CMF. However, in the presence of CMF, the rate of GTP 
hydrolysis is drastically reduced to approximately 51 molecules in 3 minutes. Since 
lysates from cells lacking Gα2 have no cAMP-stimulated GTP binding or hydrolysis, 
these results argue that quorum sensing through CMF is accomplished by controlling the 
cAMP-stimulated GTPase activity of Gα2. 
 
CMF exerts its effect on cAMP-cAR1-Gα2 signaling through its own G protein signaling 
cascade. CMF has its receptor on the cell surface [29], which is coupled with Gα1βγ 
protein [30]. After CMF binds to its receptor, Gβγ will be able to activate phospholipase 
C (PLC), which in turn regulates the GTPase activity of Gα2 [30]. PLC is stimulated to 
produce IP3 and DAG in mammals [31]. This IP3 increases intracellular [Ca2+], which is 
known to activate protein kinase C (PKC) [32-34]. DAG also activates PKC directly [35]. 
CMF has been found to stimulate PKC activity in D. discoideum (unpublished data). 
Thus it is reasonable to imagine that PKC is likely downstream to PLC in the CMF-Gα1 
pathway (Figure 3). 
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Figure 3. CMF signal pathway. 
CMF binds to its cell surface receptor, which is coupled with Gα1βγ protein. Gβγ activates downstream 
PLC and PKC. 
 
 
In mammalian cells, PKC regulates downstream phospholipase D (PLD) [36]. 
Additionally, phosphatidic acid, a product of phosphatidylcholine hydrolysis by PLD, has 
been shown to control the GTPase activity of Gα proteins via RGS (regulator of G 
protein signaling) proteins [37]. Together, these findings suggest the involvement of PLD 
in quorum sensing. In this project, we have a hypothesis that PldB, a homologue of PLD, 
mediates quorum sensing in the CMF signal pathway (Figure 4). CMF signal pathway 
decreases the GTPase activity of Gα2 and prolongs the lifetime of Gα2-GTP. This keeps 
Gα2 in its active form, allowing the activation of adenylyl and guanylyl cyclases, and 
makes following chemotaxis and aggregation possible.  
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Figure 4. CMF pathway regulates cAMP pathway by decreasing the GTPase activity of Gα2. 
We hypothesize that PldB has a negative role in aggregation by increasing the GTPase activity of Gα2 and 
lies downstream of phospholipase C in the CMF signal pathway. PldB activity is inhibited upon CMF 
binding. 
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1.6 Phospholipase D  
1.6.1 Definition 
A phospholipase is an enzyme that converts phospholipids to fatty acids and other 
lipophilic substances. There are four major classes: A, B, C and D. Phospholipase D 
(PLD) has two biochemical activities: phosphodiester bond hydrolysis and phospholipid 
transphosphatidylation. As a phospholipid hydrolysis enzyme, PLD cleaves 
phosphatidylcholine (PC) to yield phosphatidic acid (PA) and choline, using H2O as an 
electron donor (Figure 5). If alcohol replaces H2O, PLD can generate 
phosphotidylalcohols. In mammalian cells, there are two classes of PLD activities [38]. 
One class is phosphoinositide-independent, fatty-acids-activated PLD. No corresponding 
cDNA sequences have been reported for this class. The other is phosphoinositide-
dependent PLD, which is inhibited by free fatty acids. cDNA cloning revealed two 
proteins of this class: PLD1 from human HeLa cells and PLD2 from mouse cells. They 
share 50% homology.  
 
H2O
CH2 O C R
O
CH O C R’
O
CH2
O
P
O¯
O O CH2 CH2 N+(CH3) 3
PLD
CH2 O C R
O
CH O C R’
O
CH2
O
P
O¯
O
+
Phosphatidylcholine Choline
OH
HO CH2 CH2 N+(CH3) 3
Phosphatidic Acid  
Figure 5. Phosphatidylcholine hydrolysis. 
In the presence of water, PLD cleaves the phosphodiester bond in phosphatidylcholine to produce 
phosphatidic acid and choline. 
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1.6.2 Structure 
The structure of PLD contains two conserved catalytic ‘HKD’ motifs (also known as 
conserved region (CR) II and IV, or the transphosphatidylation domains), disruption of 
which leads to loss of catalysis function [38] (Figure 6). An ‘IYIENQFF’ motif (CRIII) is 
found only in those that have bona fide activity, with a possible role of interacting with 
the choline headgroup of PC. CRI and a pleckstrin homology (PH) domain in the 
structure interact with phosphoinositol-4,5-biphosphate (PIP2) in the membrane, keeping 
the PLD membrane bound and catalytically active [39]. A phox consensus sequence (PX) 
motif is reported to mediate protein-protein interactions [40]. The amino-termini of PLDs 
are poorly conserved and can tolerate significant modifications, such as fusion to green 
fluorescent protein (GFP) without changes in enzyme activity [41, 42]. On the contrary, 
the carboxy-termini are relatively well conserved and intolerant to modifications [41, 42]. 
PLD1 encodes a loop region of 100-150 amino acids at the center of the protein that is 
not present in PLD2 or most other PLDs from lower organisms [43, 44]. It is highly 
variable and does not seem to affect enzyme activity or localization when modified [45]. 
 
Figure 6. Schematic depiction of human PLD1. 
Boxes, location of regions of highly conserved sequence or regions unique to PLD1 (loop sequence). P, site 
of tyrosine phosphorylation in mPLD2. This figure is from Reference #38. 
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1.6.3 Localization and regulation 
PLD2 is localized to plasma membrane and only activated by lipids PIP2 and 
phosphoinositol-3,4,5-triphosphate (PIP3) [46]. PLD1 is usually found in perinuclear 
regions and vesicles [46]. Besides PIP2 and PIP3, PLD1 can also be activated by GTP 
binding proteins (ARF and Rho families of GTPases), protein kinase C (PKC), tyrosine 
kinases and Ras subfamily of small G proteins [38, 46-49]. PKC activates PLD either 
through phosphorylation of PLD itself, or a phosphorylation-independent mechanism 
where certain PKC isoenzymes activate PLD [50, 51]. Down-regulation of PKC or 
addition of PKC inhibitors impairs receptor mediated PLD activation [52].  
 
1.6.4 Function in mammals 
Besides the obvious role in phospholipid turnover and maintenance of the structural 
integrity of cellular or intracellular membranes, PLD and its phospholipid hydrolysis 
product PA are involved in a multitude of cellular events [53]. PLD1 activity is 
implicated in the budding of COPI-coated Golgi vesicles, the formation of nascent 
secretory vesicles in the trans-Golgi network, ARF-dependant clathrin coat assembly in 
the enodosomal/lysosomal system, and the regulated exocytotic secretion [54]. PLD1 also 
plays a role in survival pathways that prevent apoptosis [55]. PLD2 has suggested 
functions in actin cytoskeletal rearrangement and receptor-triggered ARF-mediated 
endocytic process [54]. Moreover, PA is proposed to mediate the activation of NADPH 
oxidase, or the respiratory burst, leading to the release of active oxygen radicals [53]. 
Thus, determining the roles of PLD in various cellular responses will greatly benefit our 
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understanding of the corresponding molecular cell biology and biochemistry, which may 
guide us in therapeutic designs for different diseases. 
 
1.6.5 PldB in D. discoideum 
In D. discoideum cells, inhibition of PLD activity by butanol leads to aberrant 
relocalization of F-actin and impaired phagocytosis and pinocytosis [56]. These effects 
by butanol can be reversed by exogenous PA, confirming the effects are caused by 
inhibition of PLD activity. These findings suggest that localized PLD activity is essential 
for normal actin distribution and endocytosis. In this project, we describe the role of a 
putative phospholipase D homologue, PldB, in D. discoideum development. 
 
To identify genes that encode PLD proteins in D. discoideum, a BLAST search is 
performed against the database of the Japanese Dictyostelium cDNA project by using the 
human phosphatidylcholine-specific PLD1 amino acid sequence as a query. Two 
different partial cDNAs are identified. Another BLAST search is performed against the 
database of the Dictyostelium Genome project by using the partial cDNAs as queries. 
Contigs containing these sequences are identified, yielding large putative open reading 
frames for both genes. These genes are named pldA and pldB. pldA is expressed 
consistently in both vegetative and developing cells, while pldB is differentially regulated 
(unpublished data). pldB is chosen for further study due to its expression pattern. 
 
The pldB gene resides on chromosome 3, is 2,747 nucleotides long with one predicted 
intron, and codes for a hypothetical protein of 867 amino acids with a molecular weight 
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of ~100-kDa. The translated protein contains the conserved regions found in all PLD1’s 
including a PH domain, catalytic region I (CRI), CRII, a loop, CRIII, CRIV, and the C-
terminal tail (Figure 7). Overall, the protein shares 32% similarity and 21% identity with 
PLD1 from humans. Excluding the N terminus and loop domains, which vary widely 
from species to species, PldB has 51% similarity and 34% identity to PLD1 from humans. 
 
 
 
Figure 7. Comparison of the predicted amino acid sequences of the catalytic regions of PLDs. 
PldB (D. disc), human PLD1 (H. sap1), human PLD2 (H. sap2), and Drosophila melanogaster PLD (D. 
mela) are aligned at the three catalytic regions. Amino acid identities are in black boldface type, while 
amino acid similarities are in gray. Similarities between PldB and human PLD1: CR II, 89%; CRIII, 90%; 
CR IV, 95%. 
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1.7 Significance 
Quorum sensing is crucial to achieve normal cell growth, differentiation and cell 
restoration for mammalian cells. Without the ability to sense the number of cells present, 
an organ or tissue will not stop cell division when it reaches the appropriate size nor will 
it regenerate cells when damaged. While the genome of mammalian cells is not easy to 
manipulate, the single-celled eukaryote D. discoideum gives us easy genetic access to 
study quorum sensing. At the initial stage of its transformation to a multicellular 
organism, starving cells chemotax toward a common aggregation center using cAMP as 
chemoattractant. Previous studies show that cells’ sensing ability comes from a secreted 
glycoprotein CMF. CMF regulates cAMP signal pathway and relay by a signaling 
cascade involving Gα1βγ protein, PLC and PKC. Here, we demonstrate that a PLD 
homologue is involved in the CMF signal pathway, contributing to the further 
understanding of quorum sensing signal transduction. The knowledge of quorum sensing 
in D. discoideum will give us a framework to examine this phenomenon in mammalian 
cells, which can be applied in tissue and organ repair and cancer cell treatment. 
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CHAPTER 2 
Materials and Methods 
 
2.1 Cell culture 
Wild-type cells (Ax2) are grown in axenic HL5 medium (0.5% (w/v) yeast extract, 0.5% 
protease peptone, 0.5% thiotone peptone, 1% dextrose, 4.7 mM Na2HPO4, 2.5 mM 
KH2PO4, pH 6.5) on a 180 rpm shaking platform at 22°C. pldB¯ cells and pldBOE cells 
are grown in the same shaking culture as above containing 10 μg blasticidin/ml and 20 μg 
G418/ml respectively. Wild-type and pldB¯ cells are also grown on SM/5 agar plates 
with Klebsiella aerogenes. pldBOE cells are also grown on GYP agar plates with the 
blasticidin and G418 resistant strain of Escherichia coli.  
 
For development, cells at mid-log phase (2-5×106 cells/ml) are washed with PBM (20 
mM KH2PO4, 10 μM CaCl2, 1 mM MgCl2, pH 6.1 with KOH), plated on filter pads at 
1×107 cells/pad and incubated at 22°C. For aggregation competent cells, cells are starved 
in shaking PBM for 5 hours at 22°C. 
 
2.2 Low cell density aggregation assay 
Vegetative cells are collected and washed with PBM. They are then starved as submerged 
monolayer culture in a 24-well plate (BD, Franklin Lakes, NJ) at surface densities of 
224×103, 112×103, 56×103, 28 ×103, 14 ×103, and 7×103 cells/cm2 in 400 μl PBM, PBM 
supplemented with 5 μM, 25 μM, or 50 μM cell permeable phosphatidic acid, 1,2-
Dioctanoyl-sn-Glycero-3-Phosphate (Avanti, Alabaster, AL), or PBM supplemented with 
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1 μM rapamycin (Calbiochem, San Diego, CA). The plate is then incubated at 22°C for 
18 hours or longer, and examined with an inverted microscope. 
 
2.3 GTPase assay 
Cells are starved in shaking PBM at 107 cells/ml for 5 hours. Cells are then washed twice 
with PBM and resuspended in lysis buffer (40 mM HEPES/NaOH, 0.5 mM EDTA, 250 
mM sucrose, pH 7.7) to 108 cells/ml. One set of cells is lysed immediately by passage 
through a 5 μm nylon filter (GE Water & Process, Trevose, PA) on ice. The other set is 
incubated with 1 ng/ml CMF for 30 seconds and then lysed. Both sets of cells are 
centrifuged at 14,000× g at 4°C for 3 minutes. The pellets are washed with wash buffer 
(10 mM triethanolamine-HCl, pH 7.4, with 0.5 mM EDTA) and resuspended in assay 
buffer (10 mM triethanolamine-HCl, pH 7.4) to 108 cells/ml.  
 
1.5 ml tubes on ice are preloaded with 70 μl reaction mixture ( [γ-32P]GTP (0.1 
μCi/assay), 2 mM MgCl2, 0.1 mM EGTA, 0.2 mM AMP-PNP, 0.1 mM ATPγS, 10 mM 
DTT, 5 mM creatine phosphate, 0.4 mg/ml creatine phosphokinase and 2 mg/ml BSA in 
50 mM triethanolamine-HCI, pH 7.4). 10 μM cAMP and 0.01 μM or 50 μM cold GTP 
are also preloaded if required.  
 
After 5 minutes preincubation of the reaction mixture at room temperature, the reaction is 
initiated by adding 30 μl cell membrane to the 70 μl reaction mixture. The reaction is 
carried out for 1 minute and terminated by 500 μl stop buffer (50 mM sodium phosphate 
buffer, pH 2.0, with 5% (w/v) activated charcoal). All tubes are then centrifuged at 
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14,000× g at 4°C for 5 minutes and 400 μl supernatant is removed and added to 3 ml 
scintillation fluid for scintillation counting. All samples are assayed in triplicates.  
 
2.4 Northern blot analysis 
Wild-type genomic DNA, pldB upstream primer 5’-CACCATTAGCTTCCCATTGTC-3’ 
and downstream primer 5’-GGTGATCTTGCATTAGCATCCTC-3’ are used in PCR to 
produce pldB probe. The reaction is performed with NovaTaq PCR kit (EMD 
Biosciences, San Diego, CA) and contains 30 cycles of 1-minute denaturing at 94°C, 1-
minute annealing at 55°C and 1-minute extension at 72°C. The PCR product is separated 
on a 2% agarose gel and visualized with ethidium bromide. The DNA is extracted and 
purified (Millipore, Billerica, MA). 25 ng DNA probe is labeled with 32P using α-32P 
dATP (Perkin Elmer, Wellesley, MA) and DNA labeling system (Invitrogen, Carlsbad, 
CA). The labeled probe is then purified by Micro Bio-Spin 6 chromatography column 
(BioRad, Hercules, CA).  
 
RNA is isolated from cells starved on filter pads at the times indicated with the Rneasy 
mini kit (Qiagen, Valencia, CA) or Trizol reagent (Invitrogen, Carlsbad, CA). 5 μg of 
each RNA sample is run on an agarose gel, visualized by ethidium bromide staining, and 
transferred to Hybond-N+ nylon membrane (Amersham, Piscataway, NJ). Northern blot 
analysis is performed with the following partial gene fragments as DNA probes: pldB 
(250bp), cAR1 (710bp), CRAC (616bp), ACA (705bp), and IG7 (368bp). Blots with the 
same probe are incubated together in the same hybridization buffer and exposed to film 
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for the same length of time in the same film cassette. Densitometry is performed by using 
a Molecular Dynamics personal densitometer SI. 
 
2.5 Western blot analysis 
1×107 cells at mid-log phase growth are starved on filter pads for 4, 8, 12, 16, 20 and 24 
hours. They are then washed into 1.5 ml tubes with 1 ml PBM and centrifuged at 300× g 
for 5 minutes. Cell pellets are resuspended in 250 μl ddH2O with 6× SDS-PAGE sample 
buffer and heated at 95°C for 3 minutes. 20 μl of each protein sample is loaded into two 
separate 10% Tris-HCl polyacrylamide gels (BioRad, Hercules, CA). Gels are run at 80V 
for 20 minutes and then 150V till the end. The gel with unstained protein marker is 
stained with Coomassie Blue Stain for protein quantity recognition. Proteins in the other 
gel with prestained protein marker are transferred to PVDF membrane (GE Healthcare, 
Piscataway, NJ). Afterwards, the membrane is blocked with 50 ml blocking buffer (1× 
PBS, 0.1% Tween-20, 5% w/v nonfat dry milk) for 1 hour at room temperature on a 
shaker. The membrane is then incubated with 1° antibody (custom made by immunizing 
a rabbit with the synthetic peptide GCFLIVYKKKKHDEDKPS from amino acids 30 to 
47 of PldB and collecting the serum 8 weeks after the second injection and purified by 
using the above peptide attached to sepharose beads) at 0.4 μg/ml in 40 ml blocking 
buffer for 1 hour, washed with 50 ml PBST (1× PBS + 0.05% Tween-20) 3 times for 5 
minutes, incubated with 2° antibody – Anti-rabbit IgG HRP-linked antibody (Cell 
Signaling, Danvers, MA) at 10.4 ng/ml in 40 ml blocking buffer for 1 hour and washed 
with 50 ml PBST another 3 times for 5 minutes. The membrane is incubated in 
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chemiluminescent detection reagent (Pierce, Rockford, IL) for 5 minutes and exposed to 
film for 1 minute.  
 
2.6 Transphosphatidylation assay (PLD activity assay) 
Cells are incubated at 106 cells/ml in HL5 with [9,10-3H(N)]-Palmitic Acid (Perkin Elmer, 
Wellesley, MA) at 5 μCi/ml in a culture dish for 24 hours at room temperature. Cells are 
then washed with 5 ml PBM and starved in 10 ml PBM for 5 hours if required. Cells are 
resuspended in 5 ml PBM and mixed with 5 ml PBM containing 70 μl butan-1-ol or 
tertiary-butanol to achieve 0.7% final concentration, and incubated at room temperature 
for 22 minutes. PBM with butanol is removed and 500 μl of ice cold [Methanol:6N HCl 
(50:2)] is added. The cells are scraped off the plate and transferred to the first extraction 
tube (155 μl of 1N NaCl and 500 μl of ice cold chloroform) on ice. The tubes are then 
vortexed for 30 seconds and centrifuged at 14,000× g, 4°C for 2 minutes. The lower 
organic phase is transferred to the second extraction tube (350 μl ddH2O, 115 μl methanol 
and 115 μl 1N NaCl), which is vortexed for 30 seconds and centrifuged at 14,000× g, 4°C 
for 2 minutes. 10 μl of the lower organic phase of the second extraction tube is used to 
determine the total CPM of the sample. All the samples are then normalized to the total 
CPM. The normalized samples are dried under a flow of nitrogen gas and resuspended in 
30 μl of spotting solution (Chloroform:Methanol = 9:1). The tubes are then vortexed and 
let sit for 3 minutes. 10 μl of the sample is spotted at a time onto a silica-gel 60Å TLC 
plate (Whatman, Florham Park, NJ). The plate is dried at room temperature and placed 
into the TLC chamber containing 100 ml mobile phase (the upper organic phase of a 
mixture containing [Ethyl Acetate:Isooctane:Glacial Acetic Acid:ddH2O] in the ratio of 
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110:50:20:100). The solvent front is allowed to reach the top of the plate. The plate is air 
dried and sprayed with 3H enhancer spray (Perkin Elmer, Wellesley, MA) and let dry for 
20 minutes.  It is then put into a transparent plastic bag and exposed to film for 10 days at 
-80°C. The films are scanned by a densitometer and phosphatidylbutanol bands are 
quantified by ImageQuant software (GE Healthcare, Piscataway, NJ). Background is 
calculated using “local average” in the software. 
 
2.7 Cell fractionation 
Wild-type and pldB¯ cells are allowed to develop on filter pads for 16 hours and 20 hours. 
Cells are then collected in PBM and sonicated in ice water bath (Misonix, Farmingdale, 
NY). Sonication products are centrifuged at 19,000× g, 4°C for 5 minutes to separate 
membrane and cytosol fractions. 20 μg protein is boiled for 3 minutes in SDS-PAGE 
sample buffer and loaded in a 10% Tris-HCl polyacrylamide gel (BioRad, Hercules, CA), 
and Western blot analysis is performed as described above.  
 
2.8 Chemotaxis assay 
Cells are starved in shaking PBM at 2×107 cells/ml for 5 hours. All the wells of a 24-well 
Transwell plate (Corning, Corning, NY) are preloaded with 600 μl PBM and inserts are 
put into half of the wells. 7.5×105 vegetative or starved cells in 100 μl PBM are loaded 
into each insert. After 10 minutes, each insert is transferred to a new well. The inserts sit 
for another 3 minutes, after which 6 μl 1 mM cAMP is added to half of the wells. The 
plate is incubated for 3 hours at 22°C. The inserts are then removed and 3 μl 2 mM 
Calcein-AM (Calbiochem, San Diego, CA) is added to all the wells and mixed gently. 
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The plate is then incubated at room temperature for 75 minutes, protected from light. 
PBM with Calcein-AM is removed afterwards and cells are resuspended in fresh PBM. 
Fluorescence of cells is measured by a Typhoon scanner and quantified by ImageQuant 
software (GE Healthcare, Piscataway, NJ).   
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CHAPTER 3 
PldB mediates quorum sensing in the CMF pathway 
 
Quorum sensing is first studied in bacteria [4] and found to be important in cell group 
behavior and survival. Later research utilizes cells from higher organisms including 
mammals where quorum sensing is involved in cell growth, organization, differentiation 
and morphogenesis. Dictyostelium discoideum also uses quorum sensing, and unlike 
mammalian cells, D. discoideum is amenable to genetic manipulation. This has made D. 
discoideum useful in the field of quorum sensing research.  
 
Typically, a quorum sensing mechanism involves a cell-secreted molecule that cells can 
sense. This cell density sensing molecule needs to be stable under diverse environmental 
conditions and able to diffuse to a certain range so that cells in a given area can sense the 
accumulated amount of the molecule. The amount of this molecule will increase with cell 
density. When it reaches a threshold, certain genes will be induced in the cell, which may 
lead to physiological changes. In D. discoideum, two such mechanisms have been found 
during the early stages of development initiated by starvation [2].  
 
One mechanism is mediated by a molecule called prestarvation factor (PSF). PSF is 
synthesized and secreted during growth stage and accumulates in the micro-environment 
according to the density of the cells [57]. A 65-kDa glycoprotein, PSF induces expression 
of several early developmental genes during late exponential growth, including those 
encoding for aggregation stage cAMP receptor (cAR1) and the aggregation-specific form 
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of cyclic nucleotide phosphodiesterase [58]. The gene inductive effect of PSF is inhibited 
by the presence of bacteria. Production of PSF declines rapidly when cells are shifted to 
starvation conditions [58]. These observations indicate that growing cells use PSF to 
monitor their own density in relation to their food supply. When appropriate conditions 
(cell number high, food approaching depletion) are detected, PSF will induce the 
production of gene products needed to initiate cell aggregation and development. When 
the food supply is depleted, PSF production declines, chromosomal DNA synthesis 
ceases while mitochondrial DNA synthesis continues [59], and a second density sensing 
pathway comes into play. 
 
This second cell density sensing mechanism involves an 80-kDa glycoprotein named 
conditioned medium factor (CMF). Starving cells simultaneously secrete and sense CMF 
so as to coordinate cell aggregation and ensure an effectively-sized fruiting body. Cells 
will chemotax to cAMP and aggregate only when a large number of cells are starving in a 
given area, signified by a high CMF concentration (> 0.3 ng/ml) [2]. CMF realizes this 
control over aggregation by regulating the GTPase activity of Gα2 in the cAMP-cAR1- 
Gα2 signaling cascade [25]. Through its own signal pathway that includes a CMF 
receptor, Gα1βγ, PLC and a possible PKC, CMF eventually inhibits Gα2 GTPase activity, 
prolongs the lifetime of the cAMP activated Gα2-GTP configuration, and allows cAR1-
mediated cAMP signal transduction to take place [30]. Thus, downstream adenylyl and 
guanylyl cyclases will be activated, genes required for further development will be 
induced, and chemotaxis and aggregation will occur (Figure 4). 
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This project is focused on the CMF-Gα1 signal pathway with an aim to find out 
downstream signaling molecules that lead to the regulation of Gα2 GTPase activity. Here, 
we present such a molecule – PldB. 
 
3.1 PldB is a negative regulator of aggregation 
CMF based quorum sensing involves PKC and a regulator of Gα GTPase activity. Since 
PKC activates PLD in mammalian cells [36] and RGS protein is regulated by PA – a 
product of PLD activity [37], it is reasonable to imagine that PLD activity is involved in 
CMF signal pathway of quorum sensing. A preliminary low cell density assay is 
performed to examine this possibility. The ability of cells to aggregate at different 
densities is measured after treating them with butanol, which inhibits PLD function by 
blocking its ability to produce phosphatidic acid [60]. The result shows that wild-type 
cells starved in the absence of conditioned medium are only able to form aggregates 
down to 28×103 cells/cm2. Adding conditioned medium allows aggregation at 7×103 
cells/cm2. Butanol (0.1%) in the absence of conditioned medium also allows aggregation 
to occur as low as 7×103 cells/cm2, thus mimicking conditioned medium. To ensure that 
this effect is due specifically to butanol and not the presence of alcohol, the same 
experiment is performed with tertiary-butanol (0.1%), an isomer of butanol, which has no 
effect on PLD activity; these cells behave exactly like the untreated cells, aggregating 
only down to 28×103 cells/cm2. Therefore, when plated at low cell density, cells treated 
with butanol and presumably containing decreased PLD activity respond to starvation as 
if they are in the presence of CMF. This result strongly suggests that PLD activity is 
involved in quorum sensing. 
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Since butanol allows cells to aggregate at low cell density, it is reasonable to believe that 
disrupting one or both of the PLD genes would also allow cells to aggregate at low cell 
density. To examine this possibility, pldB¯ cells are created by inserting a blasticidin 
resistance cassette into the pldB locus by homologous recombination. Genomic 
integration and disruption of the pldB gene is confirmed by PCR [60]. Strains exhibiting 
proper integration of the disruption construct into the pldB gene are examined for their 
ability to aggregate at low cell density. While wild-type cells aggregate down to 28×103 
cells/cm2, pldB¯ cells are able to aggregate at 7×103 cells/cm2 (Table 1), similar to the 
observation with the addition of butanol to wild-type cells. Thus, disruption of 
phosphatidic acid production by butanol or deletion of pldB both allow aggregation at 
low cell density. The addition of exogenous CMF had no apparent effect on aggregation 
in the pldB¯ cells [60], suggesting that pldB is required by cells to properly respond to 
CMF. Therefore, starving cells lacking pldB behave as though they are at high cell 
density and are nonresponsive to conditioned medium. This suggests that PldB 
suppresses aggregation and is negatively regulated by CMF. Loss of pldB mimics the 
presence of CMF. 
 
Since pldB gene activity normally blocks aggregation, it is reasonable to believe that cells 
overexpressing pldB should be unable to aggregate at high cell density. To examine this 
possibility, strains overexpressing pldB are created by introducing a plasmid-borne copy 
of the pldB gene constitutively expressed from the actin 15 promoter into wild-type cells. 
RT-PCR [60] and Northern blot analysis (data not shown) are performed on RNA 
isolated from vegetative cells to confirm overexpression of pldB. For these pldBOE cells, 
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aggregation is inhibited even at 224×103 cells/cm2, the highest cell density examined 
(Table 1). Addition of 0.1% butanol is able to partially reverse this inhibition and allow 
aggregation at 112×103 cells/cm2 [60], suggesting that the inability to aggregate may be 
ameliorated by inhibition of PLD activity. In addition, exogenous CMF is unable to 
induce aggregation at a lower cell density [60], corroborating previous results suggesting 
that pldB is involved in the cellular response to CMF.  
 
If pldB is a negative regulator of aggregation, then enhancing its activity would preclude 
aggregation at higher and higher cell densities; the data show that this is the case. 
Likewise, removing its activity would allow cells to aggregate at any density, including 
extremely low densities, which the data also show to occur. Taken together, the data 
suggest that pldB is involved in quorum sensing as a negative regulator of aggregation 
and may lie in the CMF pathway. 
 
 
Presence of aggregates at cell density (×103 cells/cm2) of: 
Cell type 
224 112 56 28 14 7 
wild-type + + + + − − 
pldB¯ + + + + + + 
pldBOE − − − − − − 
 
 
Table 1. Ability of wild-type, pldB¯ and pldBOE cells to aggregate at low cell density. 
Cells are starved at various cell densities in submerged monolayer culture. The field of cells is then 
examined with an inverted microscope at 18 hours. The presence of aggregates is represented by a plus sign, 
while the absence of aggregates is represented by a minus sign. These are the representative results of three 
separate assays. 
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3.2 The ability of pldB¯ cells to aggregate at low cell density is cell 
autonomous  
pldB¯ cells can aggregate at low cell density while wild-type cells can not. It is possible 
that pldB¯ cells improperly secrete a diffusible factor, such as CMF, that allows them to 
aggregate at low cell density. If this were true, a small amount of pldB¯ cells, when 
mixed with wild-type cells, would secrete enough of the factor to cause the wild-type 
cells to aggregate at low cell density. To examine this possibility, wild-type cells and 
pldB¯ cells are mixed together at ratios of 1:9, 1:1, and 9:1. Their ability to aggregate at 
low cell density is examined (Table 2). The result shows that the addition of 10% pldB¯ 
cells to wild-type cells does not induce aggregation at low cell density. Conversely, the 
addition of 10% wild-type cells to pldB¯ cells does not prevent aggregation at low cell 
density. In other words, cells making up the majority in the mixture determine the 
phenotype of the mixture. Therefore, the ability of pldB¯ cells to aggregate at low cell 
density is not due to a change in cell secretion and is thus cell autonomous. 
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Presence of aggregates at cell density (×103 cells/cm2) of: 
Cell type(s) (ratio) 
224 112 56 28 14 7 
wild-type + + + + − − 
pldB¯ + + + + + + 
wild-type: pldB¯  (9:1) + + + + − − 
wild-type: pldB¯  (1:1) + + + + + − 
wild-type: pldB¯  (1:9) + + + + + + 
 
 
Table 2. Ability of mixed populations of wild-type and pldB¯ cells to aggregate at low cell density. 
Wild-type Ax2 and pldB¯ cells are mixed in different ratios and are starved at various cell densities in 
submerged monolayer culture. The field of cells is then examined with an inverted microscope at 18 hours. 
The presence of aggregates is represented by a plus sign, while the absence of aggregates is represented by 
a minus sign. These are the representative results of three separate assays. 
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3.3 PldB lies in the CMF signal pathway  
While PldB is clearly involved in quorum sensing, it is possible that this is through a 
CMF-independent pathway. CMF is demonstrated to accomplish quorum sensing by 
decreasing the GTPase activity of Gα2, keeping Gα2 in the active GTP-bound form [25]. 
Low cell density aggregation assays have shown that PldB protein is involved in quorum 
sensing and possibly in the CMF pathway. Therefore, it is reasonable to presume that 
cells without PldB protein will not have a decrease in GTPase activity of Gα2 after 
exposure to CMF, since lack of PldB breaks the CMF pathway that regulates the GTPase 
activity of Gα2. For cells overexpressing pldB, CMF should not have as much a 
decreasing effect on the GTPase activity of Gα2 as it would for wild-type cells, if there is 
any. To test this postulation, we perform GTPase activity assays to measure the GTPase 
activity of Gα2 under the influence of CMF.  
 
GTP hydrolysis in D. discoideum membranes is caused by a low-affinity GTPase and a 
high-affinity GTPase [61, 62]. cAMP binding enhances GTP hydrolysis by stimulating 
the high-affinity GTPase, but not the low-affinity GTPase [61]. This high-affinity 
GTPase activity is associated with Gα2 [25]. To assess the change in GTPase activity of 
Gα2, we need to measure the high-affinity GTPase with cAMP stimulation and presence 
of CMF. In the assay, wild-type, pldB¯ and pldBOE cells are starved for 5 hours and lysed 
with or without 30-second incubation of CMF. Cell lysates are then added to the reaction 
mixture. Half of the samples are stimulated by 10 μM cAMP. [γ-32P] GTP in the mixture 
is hydrolyzed by the GTPase activity to GDP and 32Pi. 32Pi is counted by liquid 
scintillation. Total GTPase activity is measured with the presence of 0.01 μM cold GTP. 
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Low-affinity GTPase activity is measured with the presence of 50 μM cold GTP. High-
affinity GTPase activity is calculated by subtracting low-affinity GTPase activity from 
total GTPase activity. Percent stimulation of GTPase is calculated by comparing high-
affinity GTPase with and without cAMP stimulation.  
 
As the results show, wild-type, pldB¯ and pldBOE cells all have an increase in high-
affinity GTPase activity with cAMP stimulation (Figure 8). There is no statistically 
significant (α=0.05) difference in the cAMP-stimulated percentage of GTPase between 
wild-type and pldB¯ cells, or wild-type and pldBOE cells. This demonstrates that wild-
type, pldB¯ and pldBOE cells have similar high-affinity GTPase activity after cAMP 
stimulation without the presence of CMF. However, with the presence of CMF, wild-type 
cells have a statistically significant (α=0.05) decrease in the stimulated percentage of 
GTPase activity, while pldB¯ cells and pldBOE cells do not. Thus, wild-type cells respond 
to CMF by decreasing the cAMP-stimulated high-affinity GTPase activity of Gα2. Cells 
lacking or overexpressing PldB protein appear to be nonresponsive to CMF. These 
findings match our postulation. They confirm that PldB protein is required by CMF 
signal pathway to regulate the cAMP signal pathway in quorum sensing. Therefore, PldB 
mediates quorum sensing in the CMF pathway. 
 
 
 
 
 33
0
5
10
15
20
25
30
35
40
Pe
rc
en
t s
tim
ul
at
io
n 
of
 G
TP
as
e
−CMF
+CMF
wild-type pldB¯ pldBOE  
Figure 8. Effect of CMF on cAMP-stimulated high-affinity GTPase. 
Cell lysates are stimulated with extracellular cAMP with or without the presence of CMF. Percent 
stimulation of GTPase is the increase in high-affinity GTPase between samples stimulated with cAMP and 
samples without cAMP. Data are presented as mean ± S.E.M. Statistics for the effect of CMF (paired t test; 
one-tailed p value): wild-type cells, n=5, p=0.0095; pldB¯ cells, n=3, p=0.2643; pldBOE cells, n=3, 
p=0.0650. Statistics for the difference in percent stimulation of GTPase by cAMP (unpaired t test; two-
tailed p value): wild-type cells vs. pldB¯ cells, p=0.4260; wild-type cells vs. pldBOE cells, p=0.0821.  
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3.4 Discussion 
In D. discoideum, CMF is demonstrated to be an extracellular quorum sensing signaling 
protein that regulates aggregation by decreasing the GTPase activity of Gα2 [25]. This 
makes cAMP-mediated signaling possible through Gα2βγ-bound cell surface cAMP 
receptor cAR1, which leads to expression of genes needed for cell chemotaxis and 
aggregation [25]. This CMF regulation is via a signal pathway that involves Gα1βγ and 
phospholipase C [30]. In this project, we identify a gene with sequence similarity to 
phospholipase D, pldB, and present evidence to show that it has a role in quorum sensing 
pathways.  
 
Cells lacking pldB can aggregate at low cell density, bypassing the requirement for CMF. 
This ability is cell autonomous. Cells overexpressing pldB are not able to aggregate at 
high cell density, and are thus blocked from any further development. Exogenous CMF 
will allow wild-type cells to aggregate at low cell density, but has no effect on pldBOE 
cells [60], showing that pldBOE cells are insensitive to CMF. These observations suggest 
PldB is a negative regulator of aggregation in the CMF signal pathway. PKC activity has 
been detected in D. discoideum [63], though its gene has not been cloned. This PKC 
activity is up-regulated by the presence of CMF (unpublished data). In mammalian cells, 
PLC activates PKC, which in turn activates PLD. PA, a product of PLD activity, 
regulates RGS, which regulates the GTPase activity of G proteins. These observations 
lead to our hypothesis: PldB lies downstream of PLC in the CMF signal pathway of 
quorum sensing. PldB increases the GTPase activity of Gα2. CMF triggers a decrease in 
PldB activity, and therefore GTPase activity of Gα2, allowing cell chemotaxis and 
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aggregation to occur. According to this hypothesis, cells lacking PldB have low GTPase 
activity of Gα2, as if CMF were present, and are able to aggregate at low cell density. 
Cells with high levels of constitutively expressed PldB have sustained high GTPase 
activity of Gα2 and insensitivity to CMF. cAMP signaling is therefore blocked. 
Obviously, the role of PKC in the CMF pathway needs to be clarified in future research, 
as well as the RGS protein that regulates Gα2. 
 
If our hypothesis is true, then the GTPase activity of Gα2 should be insensitive to the 
presence of CMF in cells lacking PldB protein. We have shown that this is exactly the 
case with the GTPase assay. GTPase activity of Gα2 in cells overexpressing pldB seems 
to remain unchanged with CMF. This corroborates the finding that pldBOE cells are 
insensitive to CMF in the low cell density assay. All these results fit our hypothesis. This 
leads to further investigations to reveal the properties of PldB protein.  
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CHAPTER 4 
Expression pattern, activity and localization of PldB 
 
Proteins are expressed at different time points of development so as to provide various 
functions needed by the cell. Interference with the timing of protein expression may 
result in an abnormal development program. The localization of a protein is also 
important for proper protein functions. Mislocalization could lead to diverse 
physiological aberrations or even halt development altogether. Now that we have 
confirmed that PldB protein mediates quorum sensing, we would like to find out the 
temporal and spatial characteristics of PldB by examining the RNA and protein 
expression patterns, cellular PLD activity and PldB localization in the cell. 
  
4.1 pldB mRNA is detected in developing cells 
In order to confirm the developmental regulation of PldB expression, a Northern blot 
analysis is performed with total RNA from developing wild-type cells, using a DNA 
probe generated from a fragment of pldB. The 2.8 kb pldB mRNA exhibits little or no 
expression in vegetative cells (Figure 9). Expression is apparent by 8 hours and peaks by 
16 hours. Thus pldB gene is transcribed during development. 
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Figure 9. Northern blot of total RNA from developing wild-type cells. 
Total RNA is visualized by ethidium bromide staining. Nylon membrane is probed with pldB DNA probe. 
RNA sizes are measured by RNA standard run in the same agar gel. 
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4.2 PldB protein production roughly parallels mRNA expression 
To examine production of the PldB protein, antibodies are raised against a peptide of 
PldB. These antibodies are then affinity purified with the same peptide and used to probe 
Western blots. To ensure that the antibodies are specific for PldB, antibodies are used on 
Western blots of lysates from both wild-type Ax2 cells and pldB¯ cells. Also, to examine 
developmental production of PldB, cell lysates from developing cells are used. A band at 
approximately 100-kDa appears in the wild-type sample but is absent from the pldB¯ 
sample (Figure 10), suggesting that the antibodies specifically recognize PldB. PldB is 
found in vegetative cells and protein production largely increases during development, 
peaking at 20 hours. This pattern roughly parallels that of the pldB mRNA expression. 
Thus, PldB is present during early development when quorum sensing is occurring as 
well as in later development. 
 
0               4             8             12            16    20            24
PldB protein
(~100-kDa)
Time of development (hours)
wild-type
pldB¯
 
Figure 10. Western blots of cell lysates from developing wild-type and pldB¯ cells. 
PVDF membranes are probed with PldB antibody. Protein quantities are monitored by Coomassie Blue 
staining of another gel run simultaneously with the same samples. Protein size is measured by protein 
marker run in the same gel.  
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4.3 PLD activity of wild-type, pldB knockout and pldB overexpression cells 
Western blots show that PldB protein is present throughout development. But whether 
PldB functions in cell signaling processes depends on its enzyme activity. Specifically, 
PldB is supposed to hydrolyze phosphatidylcholine to form phosphatidic acid and choline, 
which includes a phospholipid transphosphatidylation step. Thus, we examine the overall 
PLD activity in wild-type, pldB¯ and pldBOE cells with an in vivo transphosphatidylation 
assay, also known as a PLD activity assay. In this assay, primary butanol replaces H2O in 
phosphatidylcholine hydrolysis, forming metabolically stable phosphatidylbutanol 
(Figure 11). Cells are preincubated with [9,10-3H(N)] palmitic acid for 24 hours. 
Phospholipids are thus labeled with tritium atoms. The phosphatidylbutanol bands 
containing tritium atoms are separated on a thin layer chromatography plate and 
visualized on films. Tertiary-butanol can not compete as well with H2O in 
phosphatidylcholine hydrolysis. Therefore it is used as a negative control.  
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CH2 O C R
O
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O
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O
P
O¯
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O
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O
P
O¯
O
+
Phosphatidylcholine Choline
O(CH2)3CH3
HO CH2 CH2 N+(CH3) 3
Phosphatidylbutanol  
Figure 11. Transphosphatidylation assay. 
In the presence of primary butanol, PLD cleaves phosphodiester bond to form phosphatidylbutanol and 
choline. Phosphatidylbutanol with tritium atoms is then visualized through thin layer chromatography.  
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Quorum sensing happens during early development. Thus we perform the assay on 
vegetative and 5-hour starved cells. As is shown previously, D. discoideum has a basal 
level of PLD activity [56]. In our assay, under both vegetative and starvation conditions, 
pldB¯ cells show lower PLD activity than wild-type cells, while pldBOE cells show higher 
PLD activity than wild-type cells (Figure 12, Table 3). The data demonstrate that loss of 
PldB causes an overall decrease in cellular PLD activity while overexpression of PldB 
causes an overall increase in cellular PLD activity. PldB is thus a true PLD enzyme. PLD 
activity is present during quorum sensing and aggregation stages. 
 
 
phosphatidylbutanol
phosphatidylbutanol
vegetative
5-hour starved
butan-1-ol       tert-butanol butan-1-ol       tert-butanol butan-1-ol       tert-butanol
wild-type pldB¯ pldBOE
 
Figure 12. Overall PLD activity of wild-type, pldB¯ and pldBOE cells.  
In vivo transphosphatidylation assays are performed for vegetative and 5-hour starved cells. Tertiary-
butanol is used as a negative control as opposed to butan-1-ol. This is representative of three experiments. 
 
 
pldBOEpldB¯wild-type
1.390.3515-hour starved
1.210.851vegetative
Densitometry Readings (relative to wild-type)
 
Table 3. Overall PLD activity of pldB¯ and pldBOE cells relative to wild-type cells. 
Phosphatidylbutanol bands in transphosphatidylation assay are scanned by a densitometer and quantified. 
Densitometry readings of pldB¯ and pldBOE cells are adjusted relative to that of wild-type cells under 
vegetative and starvation conditions. 
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4.4 PldB is localized to cellular vesicles and/or cytoplasmic membrane 
Protein localization is important for normal enzyme activity and proper cellular functions. 
To determine the localization of PldB protein in the cell, total cell lysates are separated 
into membrane and cytosol fractions from cells at 16 and 20 hours of development on 
filter pads. These are the time points when PldB protein is at its expression peak. Western 
blot analysis is performed on both fractions. PldB protein is only observed in the 
membrane fractions of wild-type cells at 16-hour and 20-hour of development (Figure 13). 
This indicates that PldB protein is localized to cellular vesicles and/or cytoplasmic 
membrane. 
 
16hr       20hr
wild-type                     pldB¯
membrane cytosol
16hr       20hr 16hr       20hr 16hr       20hr
wild-type                     pldB¯
PldB protein
(~100-kDa)
 
Figure 13. Western blot of membrane and cytosol fractions of wild-type and pldB¯ cells.  
Cell lysates are prepared as described in Materials and Methods and probed with affinity-purified anti-PldB 
peptide antibodies. 
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4.5 Discussion 
As shown by mRNA and protein expression, PldB is present during early development, 
when quorum sensing is occurring, as well as in later development. This implies that in 
addition to its role in quorum sensing, PldB may have roles in later cell development. In 
support of this, we have found that cells lacking PldB are preferentially sorted into the 
apical region of a mound when mixed with wild-type cells, indicating they have become 
prestalk cells (unpublished data). This is consistent with the later observation that almost 
all pldB¯ cells in these mixtures end up in the stalk of the final fruiting body (unpublished 
data). This suggests that PldB is involved in cell differentiation and cell sorting during 
the mound stage when cells are divided into prestalk cells at the apical tip and prespore 
cells at the lower part. The mound stage occurs at 12 hours of development. Our Western 
blot shows that PldB is present at this time point. Also, Western blot analysis shows that 
PldB protein expression peaks at around 20 hours of development, the culmination stage, 
when the spore mass is pulled up the stalk to form a fruiting body. This suggests PldB 
may have a role in morphogenesis. Although our pldB knockout cells form similar 
fruiting bodies to those of wild-type cells, details in timing and morphology need to be 
examined. Total PLD activity is lower in pldB knockout cells and higher in pldB 
overexpressing cells. This indicates that PldB is a true PLD enzyme and its activity takes 
up a good part of the total PLD activity in D. discoideum. The lack or overexpression of 
PldB, as demonstrated by the difference in total PLD activity, causes the divergence in 
phenotypes. 
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As demonstrated by cell fractionation and Western blot analysis, PldB is localized to 
membranes and vesicles. Additionally, GFP-tagged PldB is localized to cytoplasmic 
membrane as well as vesicles in cells starved for 5 hours (unpublished data). Cell 
organelle staining shows that PldB is co-localized with lysosomes and endosomes, but 
not mitochondria (unpublished data). This could be explained by PldB structure. 
Sequence analysis shows that PldB contains all of the PLD conserved regions including a 
PH domain, CRI to CRIV, a loop, and a C-terminal domain, suggesting a member of the 
PLD1 subfamily [38]. PH domains are best known as phospholipid binding domains, but 
they have also been shown to be involved in binding to the βγ-subunits of heterotrimeric 
G proteins and protein kinase C [64, 65]. In D. discoideum, the PH domains of CRAC 
and protein kinase B are believed to be responsible for translocating these proteins to the 
plasma membrane during chemotaxis [66-68]. It has been suggested that the selective 
localization of such PH domain-containing proteins to the leading edge of the cell is what 
allows a directional response to a chemoattractant [69, 70]. Specifically, it is proposed 
that the localized activities of phosphatidylinositol 3-kinase and PTEN cause the 
accumulation of phosphatidylinositol-(3,4,5)-triphosphate at the leading edge, forming 
binding sites for PH domain-containing proteins [66, 71]. Additionally, the PH domain in 
PLD1 is suggested to be vital in protein activity for its specific and high affinity binding 
to phosphatidylinositol-(4,5)-biphosphate in lipid surfaces [48]. It is therefore feasible 
that the PH domain of PldB also allows binding to phospholipids, thus resulting in 
localized PLD activity. The PH domain of CRAC binds specifically to PI(3,4,5)P3 and 
PI(3,4)P2 [66]. To find out the phosphoinositides that the PH domain of PldB specifically 
binds to, a dot blot assay can be performed by incubating PHPldB-eGFP-His fusion protein 
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with phosphoinositides spotted on a PVDF membrane, and probing the membrane with 
anti-GFP antibodies. Additionally, glutathione-S-transferase (GST) fusion protein 
comprising GST and PHPldB can be created to investigate the possibility of PHPldB binding 
to Gβγ. Furthermore, visualizing single molecules of green fluorescent protein tagged to 
PldB or PHPldB may help reveal the dynamics of PldB localization before and during 
chemotaxis with cAMP stimulation. This technique has been demonstrated with CRAC 
[72]. 
 
In mammalian cells, PLD activity is found in multiple cellular membranes, including the 
nuclear envelope, endoplasmic reticulum, Golgi apparatus, transport/secretory vesicles 
and plasma membrane [54]. Specifically, PLD1 is enriched significantly in the Golgi 
apparatus in the perinuclear region and is also present in cell nuclei [73]. PLD1 associates 
closely with membrane fragments of Golgi apparatus and dissociates from the 
membranes with inhibition of PA synthesis. This is consistent with its role of vesicle 
trafficking from the Golgi apparatus. We show that PldB has similar subcellular 
localization in D. discoideum and has a role in quorum sensing. Additionally, loss of PLD 
activity in vegetative D. discoideum results in aberrant actin distribution and impaired 
endocytosis [56]. This suggests that PLD activity has a role in actin relocalization and 
thus phagocytosis and macropinocytosis, which are actin-based processes [74]. Vesicle 
trafficking is not only important for vegetative D. discoideum cells, when it mediates the 
food intake, but also for developing cells, where it is required for signal secretion and 
spore coat formation. This observation raises the possibility that PldB may play a role in 
actin organization and vesicle trafficking. In fact, we have found that cells overexpressing 
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pldB do not form filopodia under starvation conditions, and therefore can not have proper 
chemotaxis or aggregation (unpublished data). This confirms that PldB may regulate 
actin polymerization.  
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CHAPTER 5 
pldB¯ cells develop rapidly 
 
Knowing that PldB mediates quorum sensing and that pldB is expressed during 
chemotaxis and aggregation stage as well as later developmental stage, we wonder 
whether pldB is required for proper development of the fruiting body. To examine this 
possibility, pldB¯ cells are starved on agar and allowed to develop. The resulting fruiting 
bodies are relatively normal, with the possibility that pldB¯ fruiting bodies may have 
slightly longer stalks than wild-type fruiting bodies (Figure 14). 
 
wild-type pldB¯ 
  
Figure 14. pldB¯ cells form fruiting bodies with slightly elongated stalks. 
Wild-type Ax2 and pldB¯ cells are plated with bacteria on agar. As the bacteria are consumed, 
development is triggered. Fruiting bodies form after 24 hours. A side view of these fruiting bodies is shown. 
Bar, 1 mm. 
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To find out whether pldB is involved in the timing of aggregation, the time it takes for 
pldB¯ cells to aggregate in submerged culture is examined. Wild-type cell aggregates 
appear at 16 hours, while pldB¯ cells form aggregates by 9 hours, demonstrating that they 
aggregate more rapidly than wild-type cells (Figure 15).  
 
wild-type pldB¯  
9 hours 
 
16 hours 
Figure 15. pldB¯ cells aggregate rapidly in submerged culture. 
Cells are starved at 224×103 cells/cm2 in PBM, and photos are taken 9 and 16 hours later. Bar, 1 mm. 
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We next examine whether this is a phenomenon associated with submerged cultures by 
determining whether pldB¯ cells can develop as rapidly on filter pads. On filter pads, 
pldB¯ cells show an accelerated rate of development compared to wild-type cells. pldB¯ 
cells form aggregates by 4 hours, while wild-type cells show no signs of development. By 
6 hours, pldB¯ cells form tight aggregates, whereas wild-type cells only start streaming, 
the initial stage of aggregation. pldB¯ cells develop consistently more rapidly, forming 
fruiting bodies by 16 hours, 6 hours ahead of the wild-type cells. Thus, loss of pldB 
expression allows an earlier initiation of the developmental cycle, leading to early 
aggregation and culminating in early fruiting body formation (Figure 16). 
 
There are various reasons that might cause a rapid development phenotype. Here we 
examine two possible causes. One is increased rate of chemotaxis, which could make 
pldB¯ cells move faster and aggregate sooner. The other is earlier expression of genes 
required for chemotaxis and aggregation, which could make pldB¯ cells respond to 
external signaling molecules earlier than wild-type cells. 
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Figure 16. pldB¯ cells develop rapidly on filter pads. 
wild-type pldB¯  
4 hours 
6 hours 
 
16 hours 
Cells are deposited o filters and allowed to develop. Photos are taken at the indicated times. Bar, 3mm. 
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5.1 pldB¯ cells show normal chemotaxis to cAMP while pldBOE cells do not 
To determine whether the accelerated development seen in pldB¯ cells is due to altered 
chemotaxis, we perform a Transwell chemotaxis assay of wild-type and pldB¯ cells to 
extracellular chemoattractant cAMP. pldBOE cells are also included to examine their 
chemotactic ability. In this assay, cells are allowed to migrate through a membrane at the 
bottom of an insert to the cAMP-containing well, which accommodates the insert. The 
chemotactic index is the ratio of the number of cells migrated with cAMP to the number 
of cells migrated without cAMP. Therefore, a chemotactic index of 1 indicates that there 
is no chemotaxis to cAMP, while a chemotactic index larger than 1 indicates that there is 
chemotaxis to cAMP.  
 
Under vegetative conditions, wild-type, pldB¯ and pldBOE cells all have a chemotactic 
index around 1 (Figure 17), indicating that there is no chemotaxis to cAMP. This is in 
accordance with the phenotype that vegetative cells live as individual cells and do not 
aggregate. When cells are starved for 5 hours, wild-type and pldB¯ cells show similar 
chemotactic index around 2, indicating that there is chemotaxis to cAMP. However, 
pldBOE cells still have a chemotactic index near 1, denoting no chemotaxis to cAMP. The 
similarity in chemotactic ability between wild-type and pldB¯ cells suggests that the rapid 
development of pldB¯ cells is not caused by an increased rate of chemotaxis.   
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Figure 17. Chemotactic ability of wild-type, pldB¯ and pldBOE cells.  
Vegetative and 5-hour starved cells are used as described in Materials and Methods. Chemotactic index = 
(cells migrated with cAMP)/(cells migrated without cAMP). These are the results of three separate assays 
with standard deviation.  
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5.2 cAR1 is expressed earlier in pldB¯ cells 
To determine whether the accelerated development seen in the pldB¯ cells is due to 
earlier expression of genes required for development, a series of Northern blots are 
performed to examine the expression of three genes required early in development, cAR1 
(cAMP receptor on cell surface), CRAC (cytosol regulator of adenylyl cyclase) and ACA 
(adenylyl cyclase A), in wild-type and pldB¯ cells. For CRAC and ACA mRNA 
expression patterns, we observe no apparent difference in the timing of expression 
between wild-type and pldB¯ cells (Figure 18). However, we find that cAR1 is more 
highly expressed in pldB¯ cells under vegetative conditions than in wild-type cells 
(Figure 19A). 
 
To take a closer look at the expression pattern of cAR1 at the early stage of development, 
we isolate total RNA from vegetative cells and cells developed on filter pads at 1, 2, 3, 4, 
5, and 6 hours. We confirm that cAR1 mRNA is higher in pldB¯ cells under vegetative 
conditions than in wild-type cells (Figure 19B). In addition, cAR1 expression in pldB¯ 
cells remains consistently higher than in wild-type cells throughout the first 6 hours of 
development. cAR1 expression in pldB¯ cells peaks at 3-4 hours of development, while 
that of wild-type cells doesn’t peak until 6 hours. Thus cAR1 is expressed earlier and at 
higher levels in pldB¯ cells. This suggests that altered cAR1 expression can be one of the 
reasons that cause the rapid development phenotype of pldB¯ cells and PldB is involved 
in the timing of development. 
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Figure 18. Wild-type and pldB¯ cells have similar CRAC and ACA mRNA expressions. 
Northern blots of total cellular RNA isolated from wild-type Ax2 cells and pldB¯ cells at 4-hour intervals 
after starvation are probed with radiolabeled fragments of the crac gene and aca gene respectively. mRNA 
bands in agarose gels are stained with ethidium bromide and used to monitor RNA loading.  
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Figure 19. car1 is expressed strongly and early in pldB¯ cells.  
Northern blots of total cellular RNA isolated from wild-type Ax2 cells and pldB¯ cells at 4-hour intervals 
(A) or 1-hour intervals (B) after starvation are probed with a radiolabeled fragment of the car1 gene. The 
same blots are stripped and reprobed with a radiolabeled fragment of the IG7 gene to control for RNA 
loading. The densitometry measurements are a ratio of cAR1 to IG7, normalized to the wild-type Ax2 
vegetative sample. 
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5.3 Discussion 
In addition to allowing cells to aggregate in suboptimal density, loss of pldB also 
accelerates the developmental program. In both submerged monolayer conditions and on 
filter pads, pldB¯ cells aggregate well before wild-type cells. If loss of pldB alters the 
chemotactic ability of cells, then it might explain the rapid development phenotype 
observed in pldB¯ cells. Here we demonstrate that there is no change in chemotaxis rate 
between wild-type and pldB¯ cells at the aggregation stage. Of course, there still could be 
changes in other aspects of chemotaxis, such as when cells become chemotactically 
active, or how fast cells recover from a chemotactic pulse to cAMP, or how much lateral 
movement cells make. Such parameters of chemotaxis can be monitored through 
videomicroscopy coupled with Digital Image Analysis Software (DIAS), as depicted 
previously [75]. pldBOE cells lack chemotaxis to cAMP under starvation conditions. This 
may explain their non-aggregation phenotype. 
 
If the genes required for early development are expressed earlier in pldB¯ cells, then 
pldB¯ cells might be able to initiate development earlier and thus have the rapid 
development phenotype. Therefore, we examine the expression patterns of the early 
development genes cAR1, CRAC and ACA. cAR1 is the cAMP receptor on the cell 
surface. It mediates cAMP signaling through its coupled Gα2βγ protein. Upon cAMP 
binding, Gα2-GTP separates from Gβγ. Gβγ and CRAC together will activate 
downstream adenylyl cyclase – ACA. ACA increases intracellular cAMP, which 
regulates expression of genes needed for development and gets released extracellularly to 
relay the cAMP chemotaxis signal. There is no apparent difference in the timing of 
 56
expression of CRAC and ACA between wild-type and pldB¯ cells. The seemingly less 
expression of ACA and CRAC at 4 hours and 8 hours in pldB¯ cells would only lead to 
delayed chemotaxis and aggregation, instead of accelerated development. Thus ACA and 
CRAC are not subject to further analysis. Meanwhile, cAR1 is expressed earlier and at 
higher levels in pldB¯ cells than in wild-type cells. This suggests that pldB¯ cells may 
respond to extracellular cAMP earlier with premature cAR1 on cell surface, and thus 
initiate development earlier, causing a rapid development phenotype. The data indicate 
that altered cAR1 expression is likely one of the factors that cause the rapid development 
of pldB¯ cells, implying that PldB plays a role in the timing of development. Interestingly, 
a previous study shows that overexpressing cAR1 at growth and aggregation stages 
delays the onset of aggregation by 1-3 hours, though subsequent stages proceed normally 
[76]. This is somewhat counterintuitive since cells overexpressing cAR1 are supposed to 
respond to cAMP earlier and faster. The authors claim that the constitutively expressed 
cAR1 has similar affinity for cAMP to the endogenous one. So the possibility of 
exogenous cAR1 having lower affinity is ruled out. Our pldB¯ cells have 2.2 fold more 
cAR1 than wild-type at growth stage and 1.1-2.8 fold during early development 
(densitometry readings in Figure 19). While in their study, cAR1 is constitutively 
overexpressed at 7-40 times over growth stage and 3-5 fold over aggregation stage. This 
might cause constant adaptation of the cAR1-ACA pathway, as has been suggested 
recently [77]. This adaptation may explain the aggregation delay phenotype.  
 
Besides pldB¯ cells, Gα1¯ cells or drug treatments, such as addition of PKC activators, 
also cause aggregation at low cell density ([30]; unpublished data). But they do not have 
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the rapid development phenotype. This argues that pldB may also play a role in 
aggregation or development that is outside of CMF signal pathway. It has been reported 
that overexpressing DdPK2 or DdPK3, which encode catalytic subunits of protein kinase 
A (PKA), will cause rapid development in D. discoideum cells [78, 79]. PKA is crucial at 
all stages of D. discoideum development. Knocking out the catalytic subunit of PKA will 
preclude transcription of genes required for early development, such as acaA, pdiA, carA, 
and make cells non-aggregative [80]. It is easy to understand that overexpressing the 
catalytic subunits of PKA will cause higher PKA activity, which may lead to higher and 
earlier expression of developmental genes, and thus the rapid development phenotype. 
Since PKA regulates PLD activity in mammalian cells [81-84], it is conceivable that 
PKA may regulate PldB or vice versa in D. discoideum. If PKA inhibits PldB activity, 
then overexpressing PKA activity will mimic lack of PldB, thus leading to a rapid 
development phenotype. Or if PldB inhibits PKA activity, then overexpressing PldB will 
nullify PKA activity, thus prevent expression of early developmental genes, resulting in a 
non-aggregation phenotype. These hypotheses can be tested by measuring PLD activity 
with PKA inhibitors and activators or PKA knockout and overexpressing strains, and 
measuring PKA activity with butan-1-ol to inhibit PLD activity or pldB¯ and pldBOE cells. 
 
During D. discoideum chemotaxis, a cAMP phosphodiesterase (PDE) is secreted to 
extracellular space to reduce cAMP, terminate cAMP receptor adaptation, and prepare 
the cells for a new encounter with cAMP [85]. Overexpression of PDE leads to rapid 
aggregation, presumably because the cells spend less time in an adapted state, though 
development is arrested at mound stage [86]. Additionally, disruption of a gene that 
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contains a PDE sequence causes precocious accumulation of intracellular cAMP at 
vegetative and early development stages, and thus a rapid development phenotype [87]. 
In mammalian cells, Ca2+-stimulated intracellular redistribution of cAMP-specific 
phosphodiesterase is dependent on the PLD-mediated generation of phosphatidic acid 
[88]. These observations suggest a possibility that PldB protein might regulate PDE in D. 
discoideum. Assessing the PDE activity and its localization and secretion with pldB¯ and 
pldBOE cells may reveal the connection. 
 
Finally, EDTA-resistant cohesiveness is stronger in D. discoideum cells with rapid 
aggregation [89]. In human patients with myeloid leukemia, depression of glycosyl-
phosphatidylinositol-specific PLD activity can increase the adhesion rate of bone marrow 
mononuclear cells [90]. These facts elicit the possibility that PldB might have an 
additional role in cell-cell adhesion in D. discoideum. This can be tested with a cell 
cohesion assay, which measures the number of non-aggregated and aggregated cells from 
a shaking flask of starving cells at different time points [91]. 
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CHAPTER 6 
Downstream signaling of PldB 
 
We have hitherto shown that PldB mediates quorum sensing by suppressing aggregation. 
Cells lacking pldB can aggregate at low cell densities and have accelerated development. 
Cells overexpressing pldB can not chemotax to extracellular cAMP or form aggregates at 
even high cell densities. PldB takes effect in the CMF signal pathway that regulates the 
GTPase activity of Gα2. Naturally, we wonder what could be the downstream signaling 
molecules to PldB. Here we present evidence for two of these downstream molecules: 
phosphatidic acid (PA) and target of rapamycin (TOR). 
 
The principal PLD activity in all organisms is to hydrolyze phosphatidylcholine to create 
PA and choline. PA has been shown to be a signaling molecule in mammalian cells [92]. 
It is very likely that PldB uses PA to implement its functions in D. discoideum.  
 
The target of rapamycin (TOR) is a serine/threonine kinase highly conserved from yeasts 
to mammals that controls cell growth in response to nutrients [93]. As the name implies, 
the immunosuppressant rapamycin inhibits TOR activity by binding to the FRB region in 
the C terminus of TOR proteins [94]. In mammalian cells, mammalian target of 
rapamycin (mTOR) integrates input from multiple upstream pathways, including growth 
factors, nutrients and energy [95]. One mode of mTOR regulation by growth factor 
involves PLD1 and PA [96, 97]. The growth factor activates PLD1 via the small GTPase, 
Cdc42 (a Rho family protein), causing an intracellular increase of PA [97]. PA directly 
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interacts with the domain in mTOR that is targeted by rapamycin, and activates mTOR 
[96]. Recent studies in eukaryotic cells have identified two distinct TOR complexes, 
TORC1 and TORC2, which phosphorylate different substrates and have distinct 
physiological functions [98]. In D. discoideum cells, a TOR-containing complex that is 
related to the TORC2 of Saccharomyces cerevisiae regulates both chemotaxis and signal 
relay [75]. Three knockout strains of three distinct components of the complex all have 
non-aggregation phenotypes. The reasons are found to be loss of ACA activation and 
reduced chemotaxis rate with loss of cell polarity. This demonstrates that TOR is present 
during chemotaxis and aggregation stage and it plays a significant role in the process. 
Together, these observations imply that TOR might have a role in quorum sensing. 
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6.1 Phosphatidic acid inhibits cell aggregation 
To determine whether PA may serve as a downstream messenger of PldB in quorum 
sensing pathways, we perform low cell density assays with exogenous cell permeable 
phosphatidic acid. Both wild-type and pldB¯ cells show aggregation inhibition with 
various concentrations of PA (Table 4), mimicking the phenotype of pldBOE cells. 
Obviously, overexpressing pldB will raise the level of intracellular PA, thus having an 
effect on cell aggregation similar to that of adding exogenous PA. As could be predicted, 
PA has more of an effect on wild-type cells than on pldB¯ cells at threshold levels. This 
implies that PA may be the downstream signal of PldB in the CMF signal pathway. 
 
 
Presence of aggregates at cell density (×103 cells/cm2) of: Cell type and 
treatment 224 112 56 28 14 7 
Ax2 + + + + − − 
Ax2 + 5 μM PA + + − − − − 
Ax2 + 25 μM PA + − − − − − 
Ax2 + 50 μM PA − − − − − − 
pldB¯ + + + + + + 
pldB¯ + 5 μM PA + + + + + − 
pldB¯ + 25 μM PA + − − − − − 
pldB¯ + 50 μM PA − − − − − − 
 
 
Table 4. Effect of phosphatidic acid (PA) on low cell density aggregation. 
Wild-type Ax2 cells and pldB¯ cells are starved at various cell densities in submerged monolayer culture in 
the absence or presence of PA. The field of cells is then examined with an inverted microscope at 22 hours. 
The presence of aggregates is represented by a plus sign, while the absence of aggregates is represented by 
a minus sign. These are the representative results of three separate assays. 
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6.2 Rapamycin promotes cell aggregation 
To examine the possibility of TOR being involved in quorum sensing, a low cell density 
assay is performed with rapamycin. The results demonstrate that rapamycin promotes cell 
aggregation at lower cell densities for all cell types tested (Table 5). Rapamycin in wild-
type cells mimics loss of pldB, making cells aggregate at 14×103 cells/cm2. This suggests 
that TOR is involved in quorum sensing and it could be upstream or downstream of PldB. 
However, rapamycin also has an aggregation-promoting effect on pldB¯ and pldBOE cells. 
This implies that TOR is actually downstream of PldB. 
 
Presence of aggregates at cell density (×103 cells/cm2) of: 
Cell type and treatment 
112 56 28 14 7 3.5 
Ax2 + + + − − − 
Ax2 + 1 μM rapamycin + + + + − − 
pldB¯ + + + + + − 
pldB¯ + 1 μM rapamycin + + + + + + 
pldBOE − − − − − − 
pldBOE + 1 μM rapamycin + − − − − − 
 
 
Table 5. Effect of rapamycin on low-cell-density aggregation. 
Wild-type Ax2 cells, pldB¯ cells and pldBOE cells are starved at various cell densities in submerged 
monolayer culture in the absence or presence of rapamycin. The field of cells is then examined with an 
inverted microscope at 47 hours. The presence of aggregates is represented by a plus sign, while the 
absence of aggregates is represented by a minus sign. These are the representative results of three separate 
assays. 
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6.3 Discussion 
The enzyme activity of PLD is the hydrolysis of phosphatidylcholine to phosphatidic acid 
(PA) and choline. PA has been identified as a second messenger in cell signal 
transduction [92]. It is then natural to imagine that PA has a role in quorum sensing as a 
product of PldB activity. Low cell density assays are performed to investigate this 
possibility with a series of increasing PA concentrations. The results confirm the 
involvement of PA in quorum sensing. Exogenous PA makes cells unable to aggregate at 
high cell densities, just as overexpressing pldB will do. Obviously, overexpressing pldB 
will increase PA production, which is mimicked by adding exogenous PA. The data are 
consistent with PldB taking effect in the CMF signal pathway through PA production. 
 
In view of PA regulating TOR in mammalian cells and the requirement of a TOR 
complex for aggregation in D. discoideum, we wonder whether TOR has a role in quorum 
sensing. Again, low cell density assays are performed with rapamycin to inhibit TOR 
activity. Addition of rapamycin causes wild-type, pldB¯ and pldBOE cells to aggregate at 
lower cell densities than they would without rapamycin. This phenotype is similar to that 
of knocking out pldB gene. This indicates TOR is involved in quorum sensing and 
probably downstream of PldB, and therefore PA.  
 
With these data, it is reasonable to come up with this hypothesis: PA activates TOR, and 
TOR eventually increases GTPase activity of Gα2. Since PA and rapamycin both interact 
with the same domain in TOR, exogenous rapamycin will compete with endogenous PA 
in binding to TOR. TOR is then less activated, thus GTPase activity of Gα2 is lower. Gα2 
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is preferentially kept at active GTP-bound form, and chemotaxis and aggregation are 
allowed to occur. Conversely, overexpressing PldB results in elevated PA production, 
which makes TOR highly activated. Consequently, GTPase activity of Gα2 is high. Gα2 
is preferentially kept at inactive GDP-bound form, and chemotaxis and aggregation are 
not allowed to occur. 
 
It is interesting to notice that for the mammalian TOR-containing multiprotein complexes, 
TORC1 is sensitive to rapamycin while TORC2 is not [99]. Correspondingly, a putative 
TORC1 is present during growth of D. discoideum [75]. Rapamycin inhibits cell growth, 
and knocking out the TOR gene seems to be lethal to cells. Yet TORC2, mutation of 
whose components results in non-aggregation phenotype, is rapamycin-insensitive, 
because the signaling pathways that are genetically controlled by TORC2 are not 
inhibited by rapamycin [75]. Mutant strains of TORC2 do not have growth defects [75]. 
This implies that a TORC1 controls the growth of D. discoideum while a TORC2 plays a 
role during development. Our data demonstrate that the TOR involved in quorum sensing 
is sensitive to rapamycin. Suppressing its activity leads to aggregation at lower densities, 
instead of non-aggregation. Thus this TOR complex doesn’t seem to be TORC2, but 
TORC1. This implies that the TORC1 controlling cell growth may still be available 
during development, at least the initial quorum sensing stage. If so, then both TORC1 and 
TORC2 are present during the transition stage from growth to development. To 
determine whether TORC1 and TORC2 are directly involved in the CMF quorum sensing 
pathway, performing low cell density assay and GTPase assay of Gα2 on TORC2 mutant 
strains and TORC1 overexpressing strains will be helpful. 
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On the other hand, PA is a regulator of RGS (regulator of G protein) activity. Specifically, 
mammalian RGS4 is inhibited by PA [37]. RGS proteins act as GTPase activating 
proteins for heterotrimeric G proteins. The controlling effect of CMF on GTPase activity 
of Gα2 is indirect and involves a G protein-coupled signaling cascade. An RGS protein is 
most likely directly responsible for controlling the GTPase. This RGS protein could be 
regulated by PA produced by PldB. Therefore, PldB, through localization provided by its 
PH domain, could be involved in localized regulation of Gα2, the G protein mediating 
cAMP chemotaxis. Given that G proteins in chemotaxing cells are evenly distributed 
along the membrane [100], localized control of G protein activity could help to influence 
the polarization of a chemotaxing cell. Specifically, a gene encoding RGS domain-
containing protein kinase (RCK1) has been identified in D. discoideum [101]. RCK1 is 
preferentially expressed at the aggregation stage of development. rck1 null cells 
chemotax approximately 50% faster than wild-type cells, while overexpression of wild-
type RCK1 reduces chemotaxis speed by approximately 40%. This suggests that RCK1 
plays a negative regulatory role in chemotaxis and is consistent with a putative function 
of activating GTPase activity of Gα2. Upon cAMP stimulation, RCK1 transiently 
translocates to the membrane region with similar kinetics of membrane localization of the 
PH domain-containing proteins. Further genetic evidence suggests that Gα2 may directly 
interact with RCK1. This report is intriguing in that this RGS domain-containing protein 
kinase can possibly be involved in quorum sensing and directly regulate the GTPase 
activity of Gα2. It would be interesting to examine the role of this RGS protein in quorum 
sensing with low cell density assay and GTPase assay of Gα2, identify its substrate with 
GST fusion protein technique, and deduce its connection with PA and TOR. 
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CHAPTER 7 
Summary 
 
We present evidence to show that a putative PLD homologue, PldB, mediates quorum 
sensing in Dictyostelium discoideum development by negatively regulating cell 
aggregation. Cells lacking pldB can aggregate at low cell density. This phenotype is cell 
autonomous. Cells overexpressing pldB are unable to aggregate even at high cell density. 
PldB functions in the CMF signal pathway that regulates the cAMP signal pathway by 
decreasing the cAMP-stimulated GTPase activity, allowing cell chemotaxis and 
aggregation to occur. cAMP-stimulated GTPase activities in pldB¯ cells and pldBOE cells 
are not responsive to CMF. Phosphatidic acid and TOR are two possible signaling 
molecules downstream of PldB in the CMF signal pathway, since addition of exogenous 
phosphatidic acid or TOR-inhibiting rapamycin inhibits and promotes cell aggregation at 
low cell density respectively. 
 
Localized to cellular vesicles as well as cytoplasmic membrane, PldB is not only present 
during early development when quorum sensing is occurring, but also in later 
development. Besides the role in quorum sensing, pldB is involved in the timing of 
development. cAMP receptor cAR1 is expressed earlier and at higher levels in pldB¯ 
cells than in wild-type cells, contributing to the rapid development phenotype of pldB¯ 
cells. However, pldB¯ cells have normal chemotaxis rate to cAMP. pldBOE cells lose 
chemotactic ability, which may explain their non-aggregation phenotype.  
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As a model organism, the discovery of a PLD enzyme in D. discoideum quorum sensing 
pathways sheds light on the path to understanding quorum sensing mechanisms in 
mammalian systems. Monitoring cell number while manipulating PLD activities would 
be a feasible start. Moreover, our results indicate the involvement of a TOR-containing 
multiprotein complex in quorum sensing pathways, as rapamycin disrupts quorum 
sensing. This TOR complex is likely the one in charge of vegetative cell growth, i.e. 
TORC1, thus disclosing a crosstalk between cell growth and quorum sensing pathways. 
A similar mechanism is seen in mammalian cells. The type 1 insulin-like growth factor 
receptor can send two seemingly contradictory signals, one for growth and one for 
differentiation, depending on a balance between two of its substrates [102]. In our case, 
TORC1 controls cell growth and also seems to mediate the quorum sensing pathway that 
leads to cell development. This possible mechanism is feasible. When cells are in 
vegetative growth and actively replicating, they do not aggregate or develop. This can be 
explained by a high PldB activity, leading to a high TORC1 activity. This eventually 
increases the GTPase activity of Gα2, inhibiting cAMP signaling. Thus, cells can not 
aggregate or develop. When starving cells enter the development program, cell growth 
stops. This can be explained by a low TORC1 activity caused by the presence of CMF 
and consequently inhibited PldB activity. This decreases the GTPase activity of Gα2, 
allowing cAMP signaling to occur. Cells can then aggregate and develop. 
 
Although how TOR controls cell growth in D. discoideum has not been clarified, 
mammalian TOR (mTOR) coordinates cell growth and proliferation by enabling mRNA 
translation through three different downstream signal pathways [103]. One is that mTOR 
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inhibits 4E binding protein 1 (4E-BP1), which then dissociates from eukaryotic initiation 
factor 4E (eIF4E), making eIF4F complex formation possible. mRNA translation will 
then be initiated. The second is that mTOR activates ribosomal protein S6 kinase 1 
(S6K1), which then activates ribosomal protein S6 (rpS6), a component of 40S ribosome. 
mRNA translation will then occur. The third is that mTOR inhibits eukaryotic elongation 
factor 2 kinase (eEF2K). This keeps eEF2 active, which can mediate translation step of 
peptide-chain elongation. A similar process may occur in D. discoideum.  
 
Increased mRNA translation as a result of up-regulated mTOR activity has been strongly 
suggested in the genesis of human cancers [95]. mTOR is activated by an upstream Ras 
homolog enriched in brain (Rheb) protein, which is a mediator of nutrient signaling. 
Rheb is inhibited by tuberous sclerosis complex (TSC1/2), which can be activated by 
AMP-activated protein kinase (AMPK), a mediator of energy homeostasis. TSC1/2 can 
also be inhibited by the growth factor insulin through PI3K/Akt pathway. Thus, the big 
picture is that nutrients, energy and growth factors have a combined regulation of mTOR 
and therefore mRNA translation. Mutations in tumor suppressors, such as PTEN 
(reverses the PI3K signaling), LKB1 (activates AMPK to sense ATP depletion) and 
TSC1/2, will result in constitutively activated mTOR. Since mTOR is required in cell 
cycle progression and has anti-apoptotic activity [104, 105], constitutive mTOR activity 
enables cancer cells to survive and proliferate. 
 
Recently, phosphatidic acid, a product of PLD activity, has been reported to activate 
mTOR as a way for cancer cells to overcome normal cellular responses to stress to 
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continue proliferation [106]. Elevated PLD activity has been implicated in various human 
cancers [107]. Similarly, our findings suggest that PldB may activate TOR in the quorum 
sensing pathway of D. discoideum. This implies that the PLD regulation of mTOR is 
possibly part of a quorum sensing mechanism. When cell size and number are below the 
optimal level, PLD activity is high. mTOR is activated and mRNA translation occurs. 
Cell cycle progression occurs. When cells reach the appropriate size and number, PLD 
activity is low. mTOR is less activated and mRNA translation slows down. Cells may be 
arrested at G1 phase and enter dormant G0 phase, or undergo apoptosis as needed. For 
tumor or cancer cells, their compromised quorum sensing mechanisms either can not 
sense the number of cells present or mistakenly sense a suboptimal level at all times. 
These cells have constitutively high PLD activity, therefore constitutively activated 
mTOR. Thus, cells keep increasing in size and number and will not go into dormancy or 
apoptosis. Rapamycin competitively binds to the region of mTOR that interacts with 
phosphatidic acid, preventing PLD activation of mTOR [108]. Therefore rapamycin 
displays a tumor suppressing effect. 
 
Overall, investigation of TOR, PLD and their upstream signals in mammalian quorum 
sensing mechanisms is a promising direction for future research. This includes finding 
out the subcellular localizations of these proteins and possible crosstalks with Rheb, 
TSC1/2 and PI3K/Akt pathways. Our work in D. discoideum reveals multiple 
physiological roles for PLD and beyond, providing a practical guide for research in 
mammalian systems, thus leading to new therapeutic designs for human cancers and 
other diseases. 
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